Cancer modeling meets human organoid technology

Area of Science:

• Biotechnology
• Cancer Research
• Regenerative Medicine

Background:

• Organoids are self-organizing 3D structures derived from stem cells in vitro.
• They mimic the structural and functional characteristics of native organs.
• Organoid technology has significantly advanced the development of human cancer models.

Purpose of the Study:

• To review the current applications and future potential of tumor organoids in cancer research.
• To highlight the use of organoids in creating patient-specific cancer models.
• To discuss the role of organoids in immune-oncology and personalized medicine.

Main Methods:

• Generating organoids from patient tumor tissues for carcinoma modeling.
• Utilizing CRISPR gene editing to engineer specific cancer gene alterations in normal organoids.
• Co-culturing tumor organoids with immune cells and fibroblasts to model the tumor microenvironment.

Main Results:

• Organoids provide versatile and accurate human cancer models.
• Engineered organoids can replicate various cancer gene alterations.
• Tumor microenvironment models enable immune-oncology applications.
• Organoids show promise in predicting patient-specific drug responses.

Conclusions:

• Tumor organoids represent a rapidly advancing field with significant implications for cancer research.
• They offer powerful tools for personalized cancer therapy and drug discovery.
• Future prospects include enhanced predictive capabilities and broader clinical applications.